Search Results

PSYCHIATRIC DISORDERS.

Subjects: *CENTRAL nervous system stimulants; *PEOPLE with mental illness; *CARE of peopleSHIRE Pharmaceuticals Group PLC SHIRE Pharmaceuticals Group PLC SHIRE Pharmaceuticals Group PLC SHPGY; NOVEN Pharmaceuticals Inc. 148585441 NOVEN Pharmaceuticals Inc. NOVEN Pharmaceuticals Inc. 148585441 148585441 NOVEN Pharmaceuticals Inc. 148585441 NOVN; JANSSEN Pharmaceutica NV

• Source: MPR - Pediatricians' Edition. Fall/Winter2014/2015, Vol. 25 Issue 2, p122-141. 20p.

Record details

PSYCHIATRIC DISORDERS.

Subjects: *CENTRAL nervous system stimulants; *ANTIPSYCHOTIC agents; *METHYLPHENIDATEJANSSEN Pharmaceutica NV ; NOVEN Pharmaceuticals Inc. 148585441 NOVEN Pharmaceuticals Inc. NOVEN Pharmaceuticals Inc. 148585441 148585441 NOVEN Pharmaceuticals Inc. 148585441 NOVN

• Source: Monthly Prescribing Reference. Nov2017, Vol. 33 Issue 10, p135-155. 21p.

Record details

Rx Products.

Subjects: *MONOCLONAL antibodies; *CENTRAL nervous system stimulantsGLAXOSMITHKLINE ; TRIS Pharma Inc. ; ALKERMES Inc. 185481132 ALKERMES Inc. ALKERMES Inc. 185481132 185481132 ALKERMES Inc. 185481132 ALKS

• Source: Pharmacy Times. Jan2016, Vol. 82 Issue 1, p35-35. 1p.

Record details

Book Review: Drug Use and Abuse.

• Authors : Rinker, Katelyn

Subjects: DRUGS of abuse; DRUG abuse; ATTENTION-deficit hyperactivity disorder

• Source: Frontiers in Psychology; 8/7/2019, p1-2, 2p

Record details

Concentr8.

• Authors : Booth, Heather

• Source: Booklist; 11/15/2015, Vol. 112 Issue 6, p50-50, 1/6p

Record details

PSYCHIATRIC DISORDERS.

Subjects: *TREATMENT of attention-deficit hyperactivity disorder; *STIMULANTSSHIRE Pharmaceuticals Group PLC SHIRE Pharmaceuticals Group PLC SHIRE Pharmaceuticals Group PLC SHPGY; JANSSEN Pharmaceutica NV ; NOVEN Pharmaceuticals Inc. 148585441 NOVEN Pharmaceuticals Inc. NOVEN Pharmaceuticals Inc. 148585441 148585441 NOVEN Pharmaceuticals Inc. 148585441 NOVN

• Source: MPR - Pharmacists' Edition. Fall2013, Vol. 7 Issue 3, p211-239. 29p.

Record details

NUVIGIL.

Subjects: *STIMULANTSCEPHALON Inc. 183236314 CEPHALON Inc. CEPHALON Inc. 183236314 183236314 CEPHALON Inc. 183236314 CEPH

• Source: MPR - Pediatricians' Edition. Fall2009/Winter2010, Vol. 20 Issue 2, pA6-A6. 1/3p. 1 Color Photograph.

Record details

CHAPTER 16: PSYCHIATRIC DISORDERS.

Subjects: *MENTAL illness treatment -- Evaluation; *STIMULANTSSHIRE Pharmaceuticals Group PLC SHIRE Pharmaceuticals Group PLC SHIRE Pharmaceuticals Group PLC SHPGY; JANSSEN Pharmaceutica NV ; NOVEN Pharmaceuticals Inc. 148585441 NOVEN Pharmaceuticals Inc. NOVEN Pharmaceuticals Inc. 148585441 148585441 NOVEN Pharmaceuticals Inc. 148585441 NOVN

• Source: Monthly Prescribing Reference. Oct2015, Vol. 31 Issue 10, p234-267. 34p.

Record details

Chapter 16: PSYCHIATRIC DISORDERS: 16A: ADHD.

Subjects: *MENTAL illness treatment; *CENTRAL nervous system stimulants; *THERAPEUTICSNOVEN Pharmaceuticals Inc. 148585441 NOVEN Pharmaceuticals Inc. NOVEN Pharmaceuticals Inc. 148585441 148585441 NOVEN Pharmaceuticals Inc. 148585441 NOVN; JOHNSON & Johnson Innovative Medicine (Company) ; NOVARTIS AG 001221845 NOVARTIS AG NOVARTIS AG 001221845 001221845 NOVARTIS AG 001221845 NVS

• Source: Monthly Prescribing Reference. Aug2014, Vol. 30 Issue 8, p240-243. 4p.

Record details

Chapter 16: PSYCHIATRIC DISORDERS: 16E: Sleep-wake disorders.

Subjects: *SLEEP disorders treatment; *CENTRAL nervous system stimulants; *THERAPEUTICSSANOFI-Aventis SA ; CEPHALON Inc. 183236314 CEPHALON Inc. CEPHALON Inc. 183236314 183236314 CEPHALON Inc. 183236314 CEPH; PFIZER Inc. 001326495 PFIZER Inc. PFIZER Inc. 001326495 001326495 PFIZER Inc. 001326495 PFE

• Source: Monthly Prescribing Reference. Aug2014, Vol. 30 Issue 8, p280-282. 3p.

Record details